• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Small molecule targeted protein degradation the UPS: venturing beyond E3 substrate receptors.小分子靶向蛋白质降解与泛素-蛋白酶体系统:超越E3底物受体的探索
RSC Med Chem. 2025 Feb 12. doi: 10.1039/d4md00718b.
2
Targeted Protein Degradation through E2 Recruitment.通过 E2 招募实现靶向蛋白降解。
ACS Chem Biol. 2023 Apr 21;18(4):897-904. doi: 10.1021/acschembio.3c00040. Epub 2023 Mar 20.
3
Isolation, characterization, and partial purification of a novel ubiquitin-protein ligase, E3. Targeting of protein substrates via multiple and distinct recognition signals and conjugating enzymes.一种新型泛素蛋白连接酶E3的分离、表征及部分纯化。通过多种不同的识别信号和缀合酶对蛋白质底物进行靶向作用。
J Biol Chem. 1996 Jan 5;271(1):302-10. doi: 10.1074/jbc.271.1.302.
4
A patent review of the ubiquitin ligase system: 2015-2018.专利审查的泛素连接酶系统:2015-2018。
Expert Opin Ther Pat. 2018 Dec;28(12):919-937. doi: 10.1080/13543776.2018.1549229. Epub 2018 Nov 23.
5
Promising new therapeutic targets for regulation of inflammation and immunity: RING-type E3 ubiquitin ligases.调控炎症和免疫反应的有前途的新治疗靶点:RING 型 E3 泛素连接酶。
Immunol Lett. 2018 Oct;202:44-51. doi: 10.1016/j.imlet.2018.08.001. Epub 2018 Aug 9.
6
Targeting E3 ubiquitin ligases for cancer therapy.靶向E3泛素连接酶用于癌症治疗。
Cancer Biol Ther. 2003 Nov-Dec;2(6):623-9.
7
Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets.环型E3连接酶的小分子调节剂:以MDM和Cullin家族为靶点
Front Pharmacol. 2018 May 8;9:450. doi: 10.3389/fphar.2018.00450. eCollection 2018.
8
Ubiquitin proteasome system in immune regulation and therapeutics.泛素蛋白酶体系统在免疫调节和治疗中的作用。
Curr Opin Pharmacol. 2022 Dec;67:102310. doi: 10.1016/j.coph.2022.102310. Epub 2022 Oct 23.
9
Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system.通过调节泛素蛋白酶体系统来控制细胞内蛋白质水平的小分子。
Angew Chem Int Ed Engl. 2014 Feb 24;53(9):2312-30. doi: 10.1002/anie.201307761. Epub 2014 Jan 23.
10
A critical discussion on the relationship between E3 ubiquitin ligases, protein degradation, and skeletal muscle wasting: it's not that simple.关于 E3 泛素连接酶、蛋白质降解和骨骼肌减少之间关系的批判性讨论:事情并非如此简单。
Am J Physiol Cell Physiol. 2023 Dec 1;325(6):C1567-C1582. doi: 10.1152/ajpcell.00457.2023. Epub 2023 Nov 13.

本文引用的文献

1
Recruitment to the Proteasome Is Necessary but Not Sufficient for Chemically Induced, Ubiquitin-Independent Degradation of Native Proteins.蛋白酶体的募集对于化学诱导的、不依赖泛素的天然蛋白质降解是必要的,但并不充分。
ACS Chem Biol. 2024 Nov 15;19(11):2323-2335. doi: 10.1021/acschembio.4c00422. Epub 2024 Oct 22.
2
Mechanisms and regulation of substrate degradation by the 26S proteasome.26S蛋白酶体对底物降解的机制与调控
Nat Rev Mol Cell Biol. 2025 Feb;26(2):104-122. doi: 10.1038/s41580-024-00778-0. Epub 2024 Oct 3.
3
Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes.利用嵌合人 E2 泛素连接酶进行靶向蛋白降解。
Commun Biol. 2024 Sep 19;7(1):1179. doi: 10.1038/s42003-024-06803-4.
4
Template-assisted covalent modification underlies activity of covalent molecular glues.模板辅助共价修饰是共价分子胶活性的基础。
Nat Chem Biol. 2024 Dec;20(12):1640-1649. doi: 10.1038/s41589-024-01668-4. Epub 2024 Jul 29.
5
Targeted protein degradation directly engaging lysosomes or proteasomes.靶向蛋白降解直接结合溶酶体或蛋白酶体。
Chem Soc Rev. 2024 Apr 2;53(7):3253-3272. doi: 10.1039/d3cs00344b.
6
Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation.利用 Cullin E3 连接酶衔接蛋白 SKP1 进行靶向蛋白降解。
ACS Chem Biol. 2024 Feb 16;19(2):442-450. doi: 10.1021/acschembio.3c00642. Epub 2024 Feb 2.
7
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitors.通过设计进行降解:新型细胞周期蛋白 K 降解剂来自旧的 CDK 抑制剂。
ACS Chem Biol. 2024 Jan 19;19(1):173-184. doi: 10.1021/acschembio.3c00616. Epub 2024 Jan 9.
8
Targeted Protein Degradation through Recruitment of the CUL4 Complex Adaptor Protein DDB1.通过募集 CUL4 复合物衔接蛋白 DDB1 实现靶向蛋白降解。
ACS Chem Biol. 2024 Jan 19;19(1):58-68. doi: 10.1021/acschembio.3c00487. Epub 2024 Jan 8.
9
The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma.细胞周期蛋白依赖性激酶12(CDK12)抑制剂SR-4835作为一种分子胶,可促进黑色素瘤中细胞周期蛋白K的降解。
Cell Death Discov. 2023 Dec 16;9(1):459. doi: 10.1038/s41420-023-01754-x.
10
Proteomic approaches advancing targeted protein degradation.蛋白质组学方法促进靶向蛋白降解。
Trends Pharmacol Sci. 2023 Nov;44(11):786-801. doi: 10.1016/j.tips.2023.08.007. Epub 2023 Sep 29.

小分子靶向蛋白质降解与泛素-蛋白酶体系统:超越E3底物受体的探索

Small molecule targeted protein degradation the UPS: venturing beyond E3 substrate receptors.

作者信息

Guo Renyu, Yang Fukang, Cherney Emily C

机构信息

Discovery & Development Sciences, Bristol Myers Squibb Co Princeton New Jersey 08543 USA

出版信息

RSC Med Chem. 2025 Feb 12. doi: 10.1039/d4md00718b.

DOI:10.1039/d4md00718b
PMID:39949641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11815867/
Abstract

The ubiquitin proteasome system (UPS) has been successfully hi-jacked by both bifunctional and monovalent small molecules to affect the degradation of proteins that were once considered undruggable. This field has primarily focused on the targeted recruitment of proteins to substrate receptors on E3 ubiquitin ligases, which are only one part of the UPS. More recently, the field has begun to explore recruitment to other types of UPS proteins including E2 ubiquitin-conjugating enzymes, substrate adaptor proteins within the E3 complex, chaperone proteins that associate with E3s, proteasomal subunits, and proteasome-associated proteins. While these approaches are relatively nascent compared to more traditional E3 substrate receptor-based degradation, these approaches are starting to show promise and could offer unique advantages. This review will cover key findings in small molecule UPS-mediated targeted protein degradation (TPD) affected by co-opting proteins beyond traditional E3 substrate receptors.

摘要

泛素蛋白酶体系统(UPS)已被双功能和单价小分子成功利用,以影响曾经被认为不可成药的蛋白质的降解。该领域主要集中于将蛋白质靶向招募到E3泛素连接酶上的底物受体,而E3泛素连接酶只是UPS的一部分。最近,该领域已开始探索招募到其他类型的UPS蛋白,包括E2泛素结合酶、E3复合物中的底物衔接蛋白、与E3相关的伴侣蛋白、蛋白酶体亚基以及蛋白酶体相关蛋白。与更传统的基于E3底物受体的降解方法相比,这些方法相对较新,但已开始显示出前景,并可能具有独特优势。本综述将涵盖小分子UPS介导的靶向蛋白质降解(TPD)中的关键发现,这些发现受到超越传统E3底物受体的蛋白质的协同作用的影响。